Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 13, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Esophageal Diseases
Interventions
COMBINATION_PRODUCT

Cellspan™ Esophageal Implant-Adult (CEI)

The CEI is a combination product consisting of an engineered synthetic scaffold (device constituent) seeded and cultured with the patient's adipose derived mesenchymal stromal cells (biologic constituent), intended to stimulate regeneration of a structurally intact, living biologic esophageal conduit, in patients requiring full circumferential esophageal reconstruction up to 6 cm segment in length.

Trial Locations (2)

48109

RECRUITING

University of Michigan, Ann Arbor

55905

RECRUITING

Mayo Clinic, Rochester

All Listed Sponsors
lead

Harvard Apparatus Regenerative Technology, Inc.

INDUSTRY